Medical Research
Electric Fields Found to Enhance Immune Response Against Glioblastoma
A recent study by the University of Southern California reveals that electric fields can significantly boost the immune system's fight against glioblastoma, offering hope for extended patient survival and new treatment avenues.
Soligenix Inc. Advances Clinical Programs with Key Trial Results Expected by 2026
Soligenix Inc. is making significant progress in its clinical programs, with critical trial results for treatments of rare diseases like cutaneous T-cell lymphoma and Behçet’s disease expected in the coming years, highlighting the company's role in addressing unmet medical needs.
Study Reveals Accelerated Biological Aging in Children with Multiple Sclerosis
New research from UC San Diego indicates that children and adolescents with multiple sclerosis experience faster biological aging, highlighting the urgent need for targeted therapies.
New Study Highlights Challenges and Systemic Barriers for Liver Cancer Patients
A recent study reveals the significant hurdles faced by hepatocellular carcinoma patients, including delayed diagnoses and social stigma, calling for systemic healthcare reforms.
GeoVax Advances Mpox Vaccine Development Amid WHO's Global Health Emergency Declaration
GeoVax Labs, Inc. is responding to the WHO's declaration of Mpox as a global public health emergency by advancing its GEO-MVA vaccine, aiming to address the urgent need for diversified vaccine supply and enhanced pandemic preparedness.
American Heart Association Launches Data Challenge to Uncover Inflammation's Role in Heart Disease
The American Heart Association has initiated the Systemic Inflammation Data Challenge to explore the connection between inflammation, marked by elevated hsCRP levels, and cardiovascular disease, aiming to improve health outcomes through advanced data science.
Tonix Pharmaceuticals to Showcase Innovations at 2025 BIO International Convention
Tonix Pharmaceuticals Holding Corp. is set to present at the 2025 BIO International Convention, highlighting its advancements in pain management and public health solutions, including a potential new treatment for fibromyalgia.
American Heart Association Certifies First Comprehensive Chest Pain Centers in India and Mexico
The American Heart Association has certified the first Comprehensive Chest Pain Centers in India and Mexico, marking a significant advancement in global cardiac care and addressing the leading cause of death worldwide.
LEKSUM and SLU Partner to Pioneer Muscle Research in Unique ICU Lab
LEKSUM LLC's collaboration with SLU establishes a groundbreaking muscle research lab, led by Dr. Lars Larsson, to study long-term ICU conditions and develop therapies for muscle myopathies affecting millions annually.
Kamada Intensifies Efforts to Highlight CYTOGAM's Role in CMV Management for Transplant Patients
Kamada Ltd. is amplifying its commitment to organ transplant patients by enhancing awareness and research around CYTOGAM, its treatment for cytomegalovirus (CMV), a potentially deadly complication for transplant recipients.
New Therapeutic Target Offers Hope in Preventing Cancer from Chronic Gut Inflammation
Research highlights a promising therapeutic target that could prevent cancer in patients suffering from chronic inflammatory bowel diseases like Crohn’s disease and ulcerative colitis, offering new hope for young patients particularly affected by these conditions.
Tonix Pharmaceuticals to Showcase Rheumatologic Research at EULAR 2025
Tonix Pharmaceuticals Holding Corp. is set to present its latest research at the Annual European Congress of Rheumatology (EULAR) 2025, highlighting advancements in rheumatologic conditions and its broader pipeline.
Cure Alzheimer’s Fund Strengthens Leadership with New Board Appointments
Cure Alzheimer’s Fund enhances its leadership team by appointing Christine Villas-Boas and Brittany Bowlen to its Board of Directors, aiming to accelerate research against Alzheimer’s disease.
Study Highlights Delayed Cancer Diagnosis in Younger Populations
Research from the University of Nottingham shows younger individuals with certain cancers face longer diagnosis times, underscoring the need for improved detection and treatment strategies.
Soligenix Inc. (SNGX) Reports Promising HyBryte Results for CTCL Treatment
Interim data from a Soligenix Inc. study highlights HyBryte's potential as a safer, faster-acting treatment for cutaneous T-cell lymphoma, offering new hope for patients with this chronic condition.
Swedish Study Reveals Potential Neurological Connection Between Autism and Parkinson's Disease
A groundbreaking research from Karolinska Institutet suggests a significant biological link between autism spectrum disorder and Parkinson's disease, potentially opening new avenues for understanding neurodegenerative conditions.
Alzamend Neuro Advances Innovative Therapies for Mental Health Disorders
Alzamend Neuro is developing novel therapeutic approaches for challenging neurological and psychiatric conditions, including Alzheimer's, Bipolar Disorder, Major Depressive Disorder, and PTSD. The company's pioneering treatments aim to improve patient outcomes by addressing current treatment limitations.
University of Houston Receives $3M Grant to Advance Cancer Immunotherapy Research
The Texas Cancer Prevention & Research Institute awarded the University of Houston $3 million to establish a biomarker core, potentially transforming cancer research and patient outcomes through advanced immunotherapy techniques.
Quantum BioPharma Advances Clinical Trial for MCAS Pain Treatment
Quantum BioPharma has received Australian ethics approval for a Phase 2 clinical trial of FSD202, a potential treatment for chronic pain associated with Mast Cell Activation Syndrome (MCAS), signaling progress in addressing a challenging medical condition.
Miami Surgeon Pioneers Zero-Pain Aesthetic Procedures with Innovative Technique
Dr. Rian Maercks of The Maercks Institute introduces a revolutionary surgical approach using Exparel, enabling aesthetic procedures with minimal pain, no opioids, and rapid recovery, potentially transforming patient experiences in plastic surgery.
American Heart Association Launches Initiative to Improve Clinical Trial Access for Rare Heart Condition
The American Heart Association is addressing healthcare disparities by launching a comprehensive initiative to improve education, outreach, and access to clinical trials for transthyretin amyloid cardiomyopathy (ATTR-CM), focusing on underrepresented populations and emerging gene editing therapies.
Breakthrough Brain Tumor Test Promises Faster Diagnosis
A new diagnostic test for brain tumors could dramatically reduce the time needed for accurate diagnosis, potentially improving patient outcomes by enabling quicker treatment decisions.
Soligenix's HyBryte Shows Promising Results in Rare Cancer Treatment
Soligenix reports significant progress in treating cutaneous T-cell lymphoma (CTCL) with its experimental therapy HyBryte, demonstrating 75% treatment success after 18 weeks of clinical trials. The breakthrough offers potential hope for patients with this challenging rare skin cancer.
Calidi Biotherapeutics Unveils Promising Cancer Therapy Platform RTNova
Calidi Biotherapeutics has developed RTNova, an innovative gene therapy platform targeting tumors with minimal damage to healthy tissues, potentially revolutionizing cancer treatment approaches.
Tonix Pharmaceuticals CEO Highlights Strategic Developments at A.G.P. Healthcare Showcase
Tonix Pharmaceuticals CEO Seth Lederman shared key strategic insights during a fireside chat, emphasizing the company's integrated business model and advanced clinical pipeline, with particular focus on potential treatments for fibromyalgia and potential defense-related medical innovations.
New Study Validates PREVENT Risk Calculator for Heart Attack Prediction
A study of nearly 7,000 adults demonstrates the accuracy of the American Heart Association's PREVENT risk calculator in identifying individuals with potential heart disease risk, using coronary calcium scores as a complementary screening tool.
New Research Illuminates Potential Link Between Epstein-Barr Virus and Multiple Sclerosis
Scientific research is uncovering a complex relationship between Epstein-Barr virus exposure and Multiple Sclerosis, highlighting the potential for deeper understanding of disease mechanisms and future treatment strategies.
Quantum BioPharma Advances Multiple Sclerosis Drug Toward Clinical Trials
Quantum BioPharma has signed an agreement with a contract research organization to prepare an Investigational New Drug application for Lucid-21-302, a potential breakthrough therapy for multiple sclerosis that could prevent neurological damage.
American Heart Association Awards $1.2 Million in Food as Medicine Research Grants
The American Heart Association has awarded $1.2 million in planning grants to 12 scientific researchers to develop clinical trial protocols exploring food intervention strategies for chronic disease management. These grants aim to test approaches that could transform healthcare delivery and potentially reduce diet-related medical costs.
Sedentary Behavior Linked to Higher Cardiac Event Risk After Hospitalization
A new study reveals that prolonged sedentary time increases the risk of subsequent cardiac events within a year after hospitalization. Replacing sitting time with light physical activity or sleep can significantly reduce cardiovascular risks.